L 669262
Alternative Names: iso-Simvastatin-6-oneLatest Information Update: 04 Aug 1999
At a glance
- Originator Merck & Co
- Class Antihyperlipidaemics
- Mechanism of Action HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 04 Aug 1999 No-Development-Reported for Hyperlipidaemia in USA (Unknown route)